2006
DOI: 10.1107/s1600536806028431
|View full text |Cite
|
Sign up to set email alerts
|

5,5-Dimethyl-2-(naphthalen-1-yloxy)-1,3,2-dioxaphosphinane 2-oxide

Abstract: Key indicatorsSingle-crystal X-ray study T = 292 K Mean (C-C) = 0.004 Å R factor = 0.048 wR factor = 0.116 Data-to-parameter ratio = 17.8For details of how these key indicators were automatically derived from the article, see

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2012
2012
2012
2012

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 4 publications
(2 reference statements)
0
2
0
Order By: Relevance
“…For the application of 4-methyl-7-hydroxycoumarin and 2-oxido-1,3,2-dioxaphosphinan derivatives, see: Babu et al(2008); Li et al (2002Li et al ( , 2006; Raghu & Reddy (1996); Sierosławski et al (2006); Zhou et al (2006). Table 1 Hydrogen-bond geometry (Å , ).…”
Section: Related Literaturementioning
confidence: 99%
See 1 more Smart Citation
“…For the application of 4-methyl-7-hydroxycoumarin and 2-oxido-1,3,2-dioxaphosphinan derivatives, see: Babu et al(2008); Li et al (2002Li et al ( , 2006; Raghu & Reddy (1996); Sierosławski et al (2006); Zhou et al (2006). Table 1 Hydrogen-bond geometry (Å , ).…”
Section: Related Literaturementioning
confidence: 99%
“…2-oxido-1,3,2-dioxaphosphinan and its derivatives exhibit high flame-retardance (Li et al, 2002;Li et al, 2006) as well as biological and pharmaceutical activity (Babu et al, 2008). Coumarin and its derivatives have a wide range of biological activities, and for years have received significant attention regarding natural and synthetic sources (Sierosławski et al, 2006;Zhou et al, 2006).…”
Section: S1 Commentmentioning
confidence: 99%